What is a tablet ? Submitted by on Sun, 11/15/2009 - 22:55 What will you gain? 1.1 Why do we need to convert an active pharmaceutical ingredient into a suitable dosage form?…

1. 1 2. SAFE HARBOR STATEMENT• Certain statements in this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation…

1. One million monkeys with typewritersAnnotations of the Genomic Data DelugeGenome Informatics AlliancePortland, 28/29 March 2012Dr. Frank Schacherer, CTO, BIOBASE [email protected]…

1. MOBILE COMPUTING IN DISTRIBUTED SYSTEM Group Members: Shafinah Kamarudin GS14607 Eizaireen Erma Ramse GS14614 Fadzlina Mohammad Azmi GS14671 Siti Haslia YaakobGS14710…

1. Essential Drug List & Rational Use of Drug Presented By- Santu M.Pharm (p’cology) ISCP Moga. 2.  The concept of essential medicines A limited range of carefully…

1. POLYMORPH PATENTS P.ILANANGAI IP CONSULTANT PATENT DEPARTMENT 2. POLYMORPH Polymorph is the abilityof a solid material toexistin more than one form or crystalstructure.…

1. table of contentsconsolidated financial statements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . page 44 notes to consolidated financial…

1. XCEL ENERGY 2003 ANNUAL REPORT 17 2. MANAGEMENT’S DISCUSSION AND ANALYSIS BUSINESS SEGMENTS AND ORGANIZATIONAL OVERVIEWXcel Energy Inc. (Xcel Energy), a Minnesota corporation,…

1. XCEL ENERGY 2003 ANNUAL REPORT 17 2. MANAGEMENT’S DISCUSSION AND ANALYSIS BUSINESS SEGMENTS AND ORGANIZATIONAL OVERVIEWXcel Energy Inc. (Xcel Energy), a Minnesota corporation,…

1. GETTING THE MOST OF YOURALLIANCE INTERNATIONALLY BYMAXIMIZING YOUR PARTNER’S RESOURCESPharmaceutical Licensing Partnerships and Alliance Management Conference July 18-19,…